|
Maxilla
|
A02.835.232.781.324.502.645 |
|
|
Remuneration
|
N01.824.417.605 |
|
|
Income
|
N01.824.417 |
|
|
Bryostatins
|
D054713 |
[A group of 20-member macrolactones in which there are three remotely substituted pyran rings that are linked by a methylene bridge and an E-disubstituted alkene, and have geminal dimethyls at C8 and C18 carbons. Some interact with PROTEIN KINASE C.
] |
|
3',5'-Cyclic-AMP Phosphodiesterases
|
D015105 |
[Enzymes that catalyze the hydrolysis of CYCLIC AMP to form adenosine 5'-phosphate. The enzymes are widely distributed in animal tissue and control the level of intracellular cyclic AMP. Many specific enzymes classified under this heading demonstrate additional spcificity for 3',5'-cyclic IMP and CYCLIC GMP.
] |
|
Echinocandins
|
D054714 |
[Cyclic hexapeptides of proline-ornithine-threonine-proline-threonine-serine. The cyclization with a single non-peptide bond can lead them to be incorrectly called DEPSIPEPTIDES, but the echinocandins lack ester links. Antifungal activity is via inhibition of 1,3-beta-glucan synthase production of BETA-GLUCANS.
] |
|
3',5'-Cyclic-GMP Phosphodiesterases
|
D015106 |
[Enzymes that catalyze the hydrolysis of cyclic GMP to yield guanosine-5'-phosphate.
] |
|
Hemorheology
|
G09.330.380.630 |
|
|
Introductory Journal Article
|
D054711 |
[Prefatory summary to a special issue or section of a journal devoted to a specific topic. This introductory text can be of varying length and substance.
] |
|
Droxidopa
|
D015103 |
[A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION.
] |
|
Salinity
|
D054712 |
[Degree of saltiness, which is largely the OSMOLAR CONCENTRATION of SODIUM CHLORIDE plus any other SALTS present. It is an ecological factor of considerable importance, influencing the types of organisms that live in an ENVIRONMENT.
] |
|
3,4-Methylenedioxyamphetamine
|
D015104 |
[An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
] |
|
Formiminoglutamic Acid
|
D02.241.081.337.351.300 |
|
|
Glutarates
|
D02.241.081.337.351 |
|
|
Health Services Misuse
|
N05.300.150.395 |
|
|
Attitude to Health
|
N05.300.150 |
|
|
Dose-Response Relationship, Radiation
|
G04.712.500 |
|
|
Radiation Tolerance
|
G04.712 |
|
|
Bone Morphogenetic Protein 1
|
D23.529.948.500 |
|
|
Tolloid-Like Metalloproteinases
|
D23.529.948 |
|
